Nasdaq-listed biotech firm Enlivex Therapeutics is raising $212 million to invest directly in a decentralized prediction market token. This massive […] The post Solana Price Prediction for 2026: Nasdaq Biotech Firm Pivots to Crypto with $212M Bet on Rain as DeepSnitch AI Targets 100x Utility Gains Ahead of Launch appeared first on Coindoo.Nasdaq-listed biotech firm Enlivex Therapeutics is raising $212 million to invest directly in a decentralized prediction market token. This massive […] The post Solana Price Prediction for 2026: Nasdaq Biotech Firm Pivots to Crypto with $212M Bet on Rain as DeepSnitch AI Targets 100x Utility Gains Ahead of Launch appeared first on Coindoo.

Solana Price Prediction for 2026: Nasdaq Biotech Firm Pivots to Crypto with $212M Bet on Rain as DeepSnitch AI Targets 100x Utility Gains Ahead of Launch

2025/11/25 20:15
5 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Nasdaq-listed biotech firm Enlivex Therapeutics is raising $212 million to invest directly in a decentralized prediction market token. This massive corporate bet on utility tokens over Bitcoin treasuries signals a new era of institutional adoption.

This shift is forcing a re-evaluation of the Solana price prediction as capital rotates into high-utility assets. Amid this trend, DeepSnitch AI is a top contender. It has already raised over $584,000 in a presale that’s getting ready to list on crypto exchanges. With the token price now at $0.02477, early investors have already locked in a 60% gain.

Nasdaq firm Enlivex raises $212 million to buy Rain token

Enlivex Therapeutics (ENLV), a clinical-stage immunotherapy company, announced on November 24th a bold plan to raise $212 million through a private investment in public equity (PIPE). The company is selling 212 million shares at $1 each to fund this strategic shift.

However, unlike other corporate treasuries that buy Bitcoin, Enlivex plans to invest the majority of this capital into Rain (RAIN), the utility token behind the Rain decentralized prediction market on the Arbitrum network.

This marks the first known corporate treasury strategy centered specifically on a prediction market token. Shai Novik, executive chairman at Enlivex, told Cointelegraph that the firm sees prediction markets as “one of the most exciting emerging sectors in the blockchain space”.

Trending coins in the market today: The SOL forecast stalls as DeepSnitch AI provides a massive profit opportunity

DeepSnitch AI: The 100x opportunity of the year

DeepSnitch AI is built for stretches like this, when Bitcoin can’t hold direction, and smaller traders feel squeezed out of every move. And yet, even in this slow market, tokens with real use still pump. Rain’s 127% jump proved it again: utility carries weight when everything else feels stuck.

If you’re new to DeepSnitch AI, it’s a trader toolkit that cuts through the noise. SnitchFeed is already active inside the team’s setup, watching large wallets and fast sentiment swings. SnitchScan is focused on catching risky contracts before people walk into trouble. Add the live dashboard and active staking, and you get a project that actually works before launch.

This is why early buyers see room for a big move. Solana and other giants can’t deliver huge multipliers anymore. DeepSnitch AI is still in presale, where small entries can turn into serious upside. A move from $0.02477 to $2.47 is the 100x path, and with audits done and features already running, it isn’t far-fetched.

Staking adds steady rewards while you hold, and early buyers are already up over 60%. With DeepSnitch AI’s launch around the corner, this price zone won’t last long.

Solana price prediction

The Solana price prediction is currently weighed down by broader market sentiment. Solana has declined by 4% as of November 24th, underperforming the overall crypto market. The Fear & Greed Index is at 19, and the technical sentiment is bearish.

The SOL price is trading below its 50-day moving average, indicating short-term weakness. While the Solana price prediction 2026 forecasts a recovery to $162.21, a 24% rise, this growth is small compared to the explosive potential of emerging utility tokens.

Rain (RAIN): The institutional favorite explodes

Rain (RAIN) has been the star of the week, increasing by more than 127% in the last seven days following the Enlivex news. This massive outperformance highlights the power of institutional backing for utility tokens.

The sentiment is bullish, and the token has recorded 18 green days in the last 30. Moreover, the price prediction for Rain is exceptionally stronger than the Solana price prediction. There are predictions of a 114% rise by mid-2026.

The bottom line

While the Solana price prediction offers steady growth, the life-changing gains are found in early-stage utility projects. DeepSnitch AI, with over 60% presale gains, is the next logical step for investors seeking 100x potential.

The presale is extremely close to selling out, and investors are aggressively accumulating as many as they can before it launches on crypto exchanges. Join now to avoid regretting what could be the biggest gem of the year.

Visit the official DeepSnitch AI website, join Telegram, and follow on X (Twitter) for the latest updates.

FAQs

What does the Enlivex investment mean for the Solana price prediction?

While Enlivex invested in an Arbitrum-based token, the move validates the broader altcoin utility narrative. This is generally positive for the long-term Solana price prediction.

Is the Solana price prediction 2026 bullish?

The Solana price prediction is moderately bullish, forecasting a 24% rise. This reflects Solana’s maturity as an asset.

How does DeepSnitch AI compare to Rain?

Both are high-utility tokens. Rain focuses on prediction markets. DeepSnitch AI focuses on market intelligence (AI agents). While Rain has already pumped 127% on news, DeepSnitch AI is still in its presale phase, offering investors a chance to get in before the major institutional news hits.


This publication is sponsored and written by a third party. Coindoo does not endorse or assume responsibility for the content, accuracy, quality, advertising, products, or any other materials on this page. Readers are encouraged to conduct their own research before engaging in any cryptocurrency-related actions. Coindoo will not be liable, directly or indirectly, for any damages or losses resulting from the use of or reliance on any content, goods, or services mentioned. Always do your own researchs

The post Solana Price Prediction for 2026: Nasdaq Biotech Firm Pivots to Crypto with $212M Bet on Rain as DeepSnitch AI Targets 100x Utility Gains Ahead of Launch appeared first on Coindoo.

Market Opportunity
Rain Protocol Logo
Rain Protocol Price(RAIN)
$0.0083928
$0.0083928$0.0083928
-4.60%
USD
Rain Protocol (RAIN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

TLDR Elliott Investment Management has built a multibillion-dollar stake in Synopsys (SNPS), per the WSJ. The activist firm wants Synopsys to generate more revenue
Share
Coincentral2026/03/23 17:00
Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

BitcoinWorld Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale Global energy markets face a sobering reality in 2025
Share
bitcoinworld2026/03/23 17:05
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11